Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:00PM GMT
Release Date Price: €131.48 (+0.41%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and I'm joined by my colleague, Robbie Marcus. And we're very pleased today to be hosting a fireside chat with J&J's management.

From the company, we have Alex Gorsky, the company's Chairman and CEO; as well as Joe Wolk, the company's CFO. So Alex and Joe, first of all, thanks for joining us today.

Questions & Answers

Christopher Thomas Schott;Alex Gorsky
JPMorgan Chase & Co, Research Division - Senior Analyst;Johnson & Johnson -

I thought maybe just to kick off, I think to say the least, we're coming off an unprecedented 2020 for the health care industry and the world as a whole. Maybe just reflect back a little bit in terms of the pandemic response and the impact you see having on the industry going forward. So what have we learned from responding to the pandemic? What can we take away from that and we've kind of built into the core business from there?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot